한글목차

산전 검사 및 신생아 스크리닝의 동향과 예측

세계 산전 검사 및 신생아 스크리닝 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 12.8%를 나타낼 전망이며, 2030년에는 108억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진 요인은 유전성 질환의 유병률 증가와 아기 염색체 증후군의 증례 증가입니다. 산전 검사 및 신생아 스크리닝 세계 시장의 미래는 병원과 진단센터 시장의 기회에서 유망하게 보입니다.

산전 검사 및 신생아 스크리닝 시장 인사이트

Lucintel의 예측에서 비침습 검사는 태아에 대한 위험이 없으며 유산 가능성도 낮기 때문에 예측 기간 동안 높은 성장이 예상됩니다.

병원은 충분한 정보를 바탕으로 의사 결정을 내리기 위해 이 시설을 선호하는 환자가 증가하고 있기 때문에 예측 기간 동안 높은 성장이 예상됩니다.

북미는 유전성 질환의 증례수가 증가하고 있으며 이 지역에 유리한 상환 정책이 존재하기 때문에 예측기간 중에 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품의 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계 산전 검사 및 신생아 스크리닝 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진 요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 산전 검사 및 신생아 스크리닝 시장 동향(2018-2023년)과 예측(2024-2030년)
• 진단 유형별 세계 산전 검사 및 신생아 스크리닝 시장
  • 침습적
  • 비침습적
• 기술별 세계 산전 검사 및 신생아 스크리닝 시장
  • 스크리닝 기술
  • 진단 기술
• 최종 용도별 세계의 산전 검사 및 신생아 스크리닝 시장
  • 병원
  • 진단센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 산전 검사 및 신생아 스크리닝 시장
• 북미 산전 검사 및 신생아 스크리닝 시장
• 유럽 산전 검사 및 신생아 스크리닝 시장
• 아시아태평양 산전 검사 및 신생아 스크리닝 시장
• 기타 지역 산전 검사 및 신생아 스크리닝 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 진단 유형별 세계의 산전 검사 및 신생아 스크리닝 시장의 성장 기회
  • 기술별 세계의 산전 검사 및 신생아 스크리닝 시장의 성장 기회
  • 최종 용도별 세계의 산전 검사 및 신생아 스크리닝 시장의 성장 기회
  • 지역별 세계의 산전 검사 및 신생아 스크리닝 시장의 성장 기회
• 세계의 산전 검사 및 신생아 스크리닝 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계 산전 검사 및 신생아 스크리닝 시장의 능력 확대
  • 세계의 산전 검사 및 신생아 스크리닝 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이선스

제7장 유력 기업의 기업 프로파일

• PerkinElmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

영문목차

Prenatal Testing & Newborn Screening Trends and Forecast

The future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030 with a CAGR of 12.8% from 2024 to 2030. The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

A more than 150-page report is developed to help in your business decisions.

Prenatal Testing & Newborn Screening by Segment

The study includes a forecast for the global prenatal testing & newborn screening by diagnostic type, technology, end use, and region.

Prenatal Testing & Newborn Screening Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

• Invasive
• Non-Invasive

Prenatal Testing & Newborn Screening Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Screening Technology
• Diagnostic Technology

Prenatal Testing & Newborn Screening Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Others

Prenatal Testing & Newborn Screening Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Prenatal Testing & Newborn Screening Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies prenatal testing & newborn screening companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prenatal testing & newborn screening companies profiled in this report include-

• Perkinelmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Prenatal Testing & Newborn Screening Market Insights

Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Hospital is expected to witness higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.

North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Features of the Global Prenatal Testing & Newborn Screening Market

Market Size Estimates: Prenatal testing & newborn screening market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Prenatal testing & newborn screening market size by diagnostic type, technology, end use, and region. in terms of value ($B).

Regional Analysis: Prenatal testing & newborn screening market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic types, technologies, end uses, and region.s for the prenatal testing & newborn screening market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the prenatal testing & newborn screening market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the prenatal testing & newborn screening market size?

Answer: The global prenatal testing & newborn screening market is expected to reach an estimated $10.8 billion by 2030.

Q.2. What is the growth forecast for prenatal testing & newborn screening market?

Answer: The global prenatal testing & newborn screening market is expected to grow with a CAGR of 12.8% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the prenatal testing & newborn screening market?

Answer: The major drivers for this market are growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.

Q.4. What are the major segments for prenatal testing & newborn screening market?

Answer: The future of the prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets.

Q.5. Who are the key prenatal testing & newborn screening market companies?

Answer: Some of the key prenatal testing & newborn screening companies are as follows:

• PerkinElmer
• Natera
• Invitae
• Centogene
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific

Q.6. Which prenatal testing & newborn screening market segment will be the largest in future?

Answer: Lucintel forecasts that non-invasive is expected to witness higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.

Q.7. In prenatal testing & newborn screening market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of genetic disorders cases and presence of favourable reimbursement policy in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the prenatal testing & newborn screening market by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Prenatal Testing & Newborn Screening Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Prenatal Testing & Newborn Screening Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 3.3.1: Invasive
  • 3.3.2: Non-Invasive
• 3.4: Global Prenatal Testing & Newborn Screening Market by Technology
  • 3.4.1: Screening Technology
  • 3.4.2: Diagnostic Technology
• 3.5: Global Prenatal Testing & Newborn Screening Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Prenatal Testing & Newborn Screening Market by Region
• 4.2: North American Prenatal Testing & Newborn Screening Market
  • 4.2.2: North American Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.3: European Prenatal Testing & Newborn Screening Market
  • 4.3.1: European Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.3.2: European Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.4: APAC Prenatal Testing & Newborn Screening Market
  • 4.4.1: APAC Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.4.2: APAC Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others
• 4.5: ROW Prenatal Testing & Newborn Screening Market
  • 4.5.1: ROW Prenatal Testing & Newborn Screening Market by Diagnostic Type: Invasive and Non-Invasive
  • 4.5.2: ROW Prenatal Testing & Newborn Screening Market by End Use: Hospitals, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Diagnostic Type
  • 6.1.2: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Technology
  • 6.1.3: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by End Use
  • 6.1.4: Growth Opportunities for the Global Prenatal Testing & Newborn Screening Market by Region
• 6.2: Emerging Trends in the Global Prenatal Testing & Newborn Screening Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Prenatal Testing & Newborn Screening Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Prenatal Testing & Newborn Screening Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PerkinElmer
• 7.2: Natera
• 7.3: Invitae
• 7.4: Centogene
• 7.5: Cradle Genomics
• 7.6: Hoffmann-La Roche
• 7.7: Quest Diagnostics
• 7.8: Baebies
• 7.9: Ravgen
• 7.10: Eurofins Scientific